| Defining the type-2 diabetic population: a first step to understanding the impact of pathway choices |
Strategic Insights |
September 2023 |
| Polypharmacy and overprescribing: overview |
Strategic Insights |
December 2022 |
| Electronic repeat dispensing: Understanding the prescribing population & initial barriers to uptake |
Strategic Insights |
June 2022 |
| North of England Integrated Care Systems; Overprescribing |
Prescribing bulletin |
September 2021 |
| Reducing the carbon impact of inhalers across the North of England |
Prescribing bulletin |
September 2021 |
| Antimicrobial prescribing across the North of England |
Prescribing bulletin |
September 2021 |
